This grant is for funding groundbreaking research aimed at dramatically transforming breast cancer prevention or treatment. The DoD’s Transformative Vision Award seeks innovative and creative proposals articulating a bold vision for significant impact, supported by a detailed implementation plan with clear milestones. Projects can span from basic science to clinical studies, striving for revolutionary outcomes. Principal Investigators must demonstrate experience leading large, focused projects. The award progresses in two phases: Phase I establishes foundational groundwork and tests core concepts, while Phase II expands the project to fully achieve the envisioned transformative impact on breast cancer.
Opportunity ID: 51454
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-TVA |
| Funding Opportunity Title: | DoD Breast Cancer Transformative Vision Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Jan 29, 2010 |
| Last Updated Date: | Feb 01, 2010 |
| Original Closing Date for Applications: | Jun 23, 2010 |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $9,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | vision for dramatically affecting the prevention or treatment of breast cancer, and a plan to test and achieve the vision as quickly as possible. The critical components of this award mechanism are:Vision: The most important aspect of the Transformative Vision Award is the articulation of the vision for a new approach to significantly impact the prevention or treatment of breast cancer. The final impact may be near-term or long-term, but the success of the vision must be transformative on breast cancer. A careful presentation of the state-of-the-art, and how the vision will transform this state, must be described.Implementation: The vision must be supported by a detailed plan that identifies critical milestones and clearly outlines the innovations and technical solutions that will be implemented to accomplish the milestones. It is expected that the proposed plan will present an exceptional level of innovation and creativity, and that the Principal Investigator (PI) will assemble the team necessary to realize the vision. The PI should have demonstrated experience in successfully leading large, focused projects. The scope of the research effort may include a broad spectrum of research spanning from basic to clinical studies, with the end result leading to a revolutionary impact on an area of paramount importance in breast cancer prevention or treatment.The Transformative Vision Award will be supported in two phases. Phase I will enable the team to lay the groundwork for the research project and to test the basic concepts of the vision. Phase II will allow the expansion of the project to proceed to accomplishment of the vision. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| The purpose of this modification is to incorporatte the application instructions into this announcement. No changes were made to the Program Announcement. | Feb 01, 2010 | |
| The purpose of this modification is to incorporate the application instructions into this announcement. No changes were made to the Program Announcement. | Feb 01, 2010 | |
| The purpose of this modification is to incorporate the application instructions into this announcement. No changes were made to the Program Announcement. | Feb 01, 2010 | |
| Feb 01, 2010 |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-TVA |
| Funding Opportunity Title: | DoD Breast Cancer Transformative Vision Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Jan 29, 2010 |
| Last Updated Date: | Feb 01, 2010 |
| Original Closing Date for Applications: | Jun 23, 2010 |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $9,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | vision for dramatically affecting the prevention or treatment of breast cancer, and a plan to test and achieve the vision as quickly as possible. The critical components of this award mechanism are:Vision: The most important aspect of the Transformative Vision Award is the articulation of the vision for a new approach to significantly impact the prevention or treatment of breast cancer. The final impact may be near-term or long-term, but the success of the vision must be transformative on breast cancer. A careful presentation of the state-of-the-art, and how the vision will transform this state, must be described.Implementation: The vision must be supported by a detailed plan that identifies critical milestones and clearly outlines the innovations and technical solutions that will be implemented to accomplish the milestones. It is expected that the proposed plan will present an exceptional level of innovation and creativity, and that the Principal Investigator (PI) will assemble the team necessary to realize the vision. The PI should have demonstrated experience in successfully leading large, focused projects. The scope of the research effort may include a broad spectrum of research spanning from basic to clinical studies, with the end result leading to a revolutionary impact on an area of paramount importance in breast cancer prevention or treatment.The Transformative Vision Award will be supported in two phases. Phase I will enable the team to lay the groundwork for the research project and to test the basic concepts of the vision. Phase II will allow the expansion of the project to proceed to accomplishment of the vision. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-TVA |
| Funding Opportunity Title: | DoD Breast Cancer Transformative Vision Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Feb 01, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $9,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | vision for dramatically affecting the prevention or treatment of breast cancer, and a plan to test and achieve the vision as quickly as possible. The critical components of this award mechanism are: Vision: The most important aspect of the Transformative Vision Award is the articulation of the vision for a new approach to significantly impact the prevention or treatment of breast cancer. The final impact may be near-term or long-term, but the success of the vision must be transformative on breast cancer. A careful presentation of the state-of-the-art, and how the vision will transform this state, must be described. Implementation: The vision must be supported by a detailed plan that identifies critical milestones and clearly outlines the innovations and technical solutions that will be implemented to accomplish the milestones. It is expected that the proposed plan will present an exceptional level of innovation and creativity, and that the Principal Investigator (PI) will assemble the team necessary to realize the vision. The PI should have demonstrated experience in successfully leading large, focused projects. The scope of the research effort may include a broad spectrum of research spanning from basic to clinical studies, with the end result leading to a revolutionary impact on an area of paramount importance in breast cancer prevention or treatment. The Transformative Vision Award will be supported in two phases. Phase I will enable the team to lay the groundwork for the research project and to test the basic concepts of the vision. Phase II will allow the expansion of the project to proceed to accomplishment of the vision. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-TVA |
| Funding Opportunity Title: | DoD Breast Cancer Transformative Vision Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 01, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $9,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | vision for dramatically affecting the prevention or treatment of breast cancer, and a plan to test and achieve the vision as quickly as possible. The critical components of this award mechanism are: Vision: The most important aspect of the Transformative Vision Award is the articulation of the vision for a new approach to significantly impact the prevention or treatment of breast cancer. The final impact may be near-term or long-term, but the success of the vision must be transformative on breast cancer. A careful presentation of the state-of-the-art, and how the vision will transform this state, must be described. Implementation: The vision must be supported by a detailed plan that identifies critical milestones and clearly outlines the innovations and technical solutions that will be implemented to accomplish the milestones. It is expected that the proposed plan will present an exceptional level of innovation and creativity, and that the Principal Investigator (PI) will assemble the team necessary to realize the vision. The PI should have demonstrated experience in successfully leading large, focused projects. The scope of the research effort may include a broad spectrum of research spanning from basic to clinical studies, with the end result leading to a revolutionary impact on an area of paramount importance in breast cancer prevention or treatment. The Transformative Vision Award will be supported in two phases. Phase I will enable the team to lay the groundwork for the research project and to test the basic concepts of the vision. Phase II will allow the expansion of the project to proceed to accomplishment of the vision. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-10-BCRP-TVA |
| Funding Opportunity Title: | DoD Breast Cancer Transformative Vision Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 01, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jun 23, 2010 |
| Archive Date: | Jul 23, 2010 |
| Estimated Total Program Funding: | $9,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | vision for dramatically affecting the prevention or treatment of breast cancer, and a plan to test and achieve the vision as quickly as possible. The critical components of this award mechanism are: Vision: The most important aspect of the Transformative Vision Award is the articulation of the vision for a new approach to significantly impact the prevention or treatment of breast cancer. The final impact may be near-term or long-term, but the success of the vision must be transformative on breast cancer. A careful presentation of the state-of-the-art, and how the vision will transform this state, must be described. Implementation: The vision must be supported by a detailed plan that identifies critical milestones and clearly outlines the innovations and technical solutions that will be implemented to accomplish the milestones. It is expected that the proposed plan will present an exceptional level of innovation and creativity, and that the Principal Investigator (PI) will assemble the team necessary to realize the vision. The PI should have demonstrated experience in successfully leading large, focused projects. The scope of the research effort may include a broad spectrum of research spanning from basic to clinical studies, with the end result leading to a revolutionary impact on an area of paramount importance in breast cancer prevention or treatment. The Transformative Vision Award will be supported in two phases. Phase I will enable the team to lay the groundwork for the research project and to test the basic concepts of the vision. Phase II will allow the expansion of the project to proceed to accomplishment of the vision. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Related Documents
Folder 51454 Full Announcement-1 -> fy10 cdmrp detailed budget and justification form-1.pdf
Folder 51454 Full Announcement-1 -> fy10 cdmrp biosketch-1.pdf
Folder 51454 Full Announcement-1 -> bcrp_fy10 tva pa_gg.pdf
Packages
| Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00016158 | Jan 29, 2010 | Jun 23, 2010 | View |
Package 1
Mandatory forms
51454 RR_SF424_1_2-1.2.pdf
51454 PerformanceSite_1_4-1.4.pdf
51454 RR_KeyPersonExpanded_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
